Ustekinumab (CNTO 1275) is a monoclonal antibody that suppresses cytokines IL-12 and IL-23.
Ustekinumab (CNTO 1275) is a medication used to treat certain inflammatory conditions by blocking the action of IL-12 and IL-23, which are involved in inflammation.